2 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Telangiectasis: new trials by email Literature Review of Telangiectasis trials Research Report on Telangiectasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pazopanib for the Treatment of Epistaxis in Hereditary Hemorrhagic Telangiectasia Pazopanib - Hereditary Hemorrhagic Telangiectasia, Epistaxis | Phase 1 / Phase 2 | Unknown | Cure HHT | 30 | 2023-07-01 | 2022-09-08 |
| Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects GTX-102 medium dose fast Period 1 and Period 2, GTX-102 medium dose slow Period 1 and Period 2, GTX-102 high dose fast Period 1 and Period 2 - Ataxia Telangiectasia | Phase 1 | Unknown | Grace Therapeutics Inc. | 48 | 2022-09-13 | 2023-01-23 |
Ataxia Telangiectasia (1) · Epistaxis (1) · Telangiectasia, Hereditary Hemorrhagic (1)
Cardiovascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Vascular Diseases (2) · Ataxia (1) · Brain Diseases (1) · Cardiovascular Abnormalities (1) · Central Nervous System Diseases (1) · Cerebellar Ataxia (1) · Cerebellar Diseases (1) · Congenital Abnormalities (1) · DNA Repair-Deficiency Disorders (1) · Dyskinesias (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1)
pazopanib (1)
Cure HHT (1) · Grace Therapeutics Inc. (1)
Canada (1)
Janice Faulknor, MD (1) · Raj Kasthuri, MD (1)